bratzler - health services advisory group

21
The Surgical Infection Prevention and Surgical Care Improvement Projects National Initiatives to Improve Surgical Care Dale W. Bratzler, DO, MPH QIOSC Medical Director 1

Upload: cardiacinfo

Post on 02-Jun-2015

607 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: Bratzler - Health Services Advisory Group

The Surgical Infection Preventionand Surgical Care Improvement Projects

National Initiatives to Improve Surgical Care

Dale W. Bratzler, DO, MPH

QIOSC Medical Director

1

Page 2: Bratzler - Health Services Advisory Group

Why focus on surgical quality?

• ~30 million major operations each year in the US• Despite advances in surgical and

anesthesia technique and improvements in perioperative care, variations in outcomes for patients having surgery are well known

Page 3: Bratzler - Health Services Advisory Group

Why focus on surgical quality?

• Among the most common complications

• surgical site infections (SSIs) and postoperative sepsis

• cardiovascular complications including myocardial infarction

• respiratory complications including postoperative pneumonia and failure to wean

• thromboembolic complications

Page 4: Bratzler - Health Services Advisory Group

Cost of Complications

• Attributable costs• Infectious complications - $1398• Cardiovascular complications - $7789• Respiratory complications - $52466• Thromboembolic complications - $18310

Dimick JB, et al. Hospital costs associated with surgical complications: a report from the private-sector National Surgical Quality Improvement Program. J Am Coll Surg. 2004;199:531-7.

Page 5: Bratzler - Health Services Advisory Group

Surgical Care Improvement ProjectNational Goal

To reduce preventable surgical morbidity and mortality by 25% by 2010

36

Page 6: Bratzler - Health Services Advisory Group

SCIP Steering Committee

• American College of Surgeons

• American Hospital Association

• American Society of Anesthesiologists

• Association of peri-Operative Registered Nurses

• Agency for Healthcare Research and Quality

• Centers for Medicare & Medicaid Services

• Centers for Disease Control and Prevention

• Department of Veteran’s Affairs

• Institute for Healthcare Improvement

• Joint Commission on Accreditation of Healthcare Organizations

37

Page 7: Bratzler - Health Services Advisory Group

Performance Measure Review

Page 8: Bratzler - Health Services Advisory Group

Surgical Site Infections (SSI)

• 2-5% of operated patients will develop SSI • 40 million operations annually in the U.S.• 0.8 - 2 million SSI’s occur annually in the U.S.

• SSI increases LOS in hospital • average 7.5 days

• Excess cost per SSI:• *$2,734-26,019 (1985, US$)• US national costs: $130-845 million/year

*Jarvis, Infect Control HospEpidemiol. 1996;17.

2

Page 9: Bratzler - Health Services Advisory Group

Quality IndicatorsNational Surgical Infection Prevention Project

• Proportion of patients who have their antibiotic dose initiated within 1 hour before surgical incision (2 hours for vancomycin or fluoroquinolones)

• Proportion of patients who receive prophylactic antibiotics consistent with current recommendations (published guidelines)

• Proportion of patients whose prophylactic antibiotics were discontinued within 24 hours of surgery end time (48 hours for cardiac surgery)

Page 10: Bratzler - Health Services Advisory Group

Revision to SCIP Inf 2

• We will allow for the use of vancomycin for prophylaxis for cardiac, vascular, and orthopedic surgery, if…

• There is a physician-documented reason in the medical record

• Beta-lactam allergy

• We may do some hospital-specific audits of vancomycin use in outlier institutions

22

Page 11: Bratzler - Health Services Advisory Group

Recently Updated Antibiotic Recommendations

Surgery Type Antimicrobial recommendations

Hip or knee arthroplasty

Preferred: Cefazolin or cefuroxime

If patient high risk for MRSA: Vancomycin*

Beta-lactam allergy:• Vancomycin or clindamycin

Cardiac or vascular

Preferred: Cefazolin or cefuroxime

If patient high risk for MRSA: Vancomycin*

Beta-lactam allergy:• Vancomycin or clindamycin

* For the purposes of national performance measurement a case will pass the antibiotic selection performance measure if vancomycin is used for prophylaxis (in the absence of a documented beta-lactam allergy) if there is physician documentation of the rationale for vancomycin use (effective for July 2006 discharges).

25

Bratzler DW, Hunt DR. Clin Infect Dis. 2006 (in press).

Page 12: Bratzler - Health Services Advisory Group

Recently Updated Antibiotic Recommendations (continued)

Surgery Type Antimicrobial recommendations

Hysterectomy • Cefotetan, cefazolin, cefoxitin, cefuroxime, or ampicillin-sulbactam

Beta-lactam allergy:• Clindamycin + gentamicin or fluoroquinolone* or aztreonam• Metronidazole + gentamicin or fluoroquinolone*• Clindamycin monotherapy

Colorectal † • Neomycin + erythromycin base; neomycin + metronidazole• Cefotetan, cefoxitin, cefazolin + metronidazole, or ampicillin-sulbactam

Beta-lactam allergy:• Clindamycin + gentamicin or fluoroquinolone* or aztreonam• Metronidazole + gentamicin or fluoroquinolone*

* Ciprofloxacin, levofloxacin, gatifloxacin, or moxifloxacin (effective for July 2006 discharges).

† For the purposes of national performance measurement, a case will pass the antibiotic selection indicator if the patient receives oral prophylaxis alone, parenteral prophylaxis alone, or oral prophylaxis combined with parenteral prophylaxis.

26

Bratzler DW, Hunt DR. Clin Infect Dis. 2006 (in press).

Page 13: Bratzler - Health Services Advisory Group

Other Points about the Antibiotic Measures

• SCIP Inf 2 – May see public reporting on Hospital Compare of July 2006 discharges

• SCIP Inf 3 – Any antibiotics given in the first 48 hours after surgery (72 hours for cardiac surgery) are considered “prophylactic” in the absence of a documented infection

Page 14: Bratzler - Health Services Advisory Group

Surgical Care Improvement ProjectNew Performance measures - Process

• Surgical infection prevention• Glucose control in cardiac surgery

patients (< 200 mg/dL)• Blood glucose closest to 0600 on PO day 1

and 2 (surgery end date is PO day 0)

• Proper hair removal• No hair removal, clippers, or depilatory

• Normothermia in colorectal surgery patients

• Temperature between 96.8-100.4° F within the first hour after leaving the OR

39

Page 15: Bratzler - Health Services Advisory Group

Cardiovascular Complication Prevention

43

Page 16: Bratzler - Health Services Advisory Group

Prevention of Cardiac EventsIntroduction

• As many as 7 to 8 million Americans that undergo major noncardiac surgery have multiple cardiac risk factors or established coronary artery disease• More than 1 million cardiac events annually

• Myocardial ischemia either clinically occult or overt confers a 9 - fold increase in risk of unstable angina, nonfatal myocardial infarction, and cardiac death

Schmidt M, et al. Arch Intern Med. 2002;162:63-69.

Mangano DT, et al. N Engl J Med. 1996;335:1713-1720.

Selzman CH, et al. Arch Surg. 2001;136:286-290.

44

Page 17: Bratzler - Health Services Advisory Group

Surgical Care Improvement ProjectPerformance measure - Process

• Perioperative cardiac events• Perioperative beta blockers in patients

who are on beta blockers prior to admission

“perioperative” is defined as 24 hours prior to incision through discharge from the post-anesthesia care/recovery area

45

Page 18: Bratzler - Health Services Advisory Group

Venous Thromboembolism Prevention

50

Page 19: Bratzler - Health Services Advisory Group

Prevention of Venous ThromboembolismIntroduction

• VTE Remains a major health problem• 200,000 new cases annually in US• In addition to the risk of sudden death

• 30% of survivors develop recurrent VTE within 10 years• 28% of survivors develop venous stasis syndrome within 20

years

• The incidence of VTE is more than 100 times greater for patients who have been hospitalized than among community dwelling

• Incidence increases with ageGoldhaber SZ. N Engl J Med. 1998;339:93-104.

Silverstein MD, et al. Arch Intern Med. 1998;158:585-593.

Heit JA, et al. Thromb Haemost. 2001;86:452-463.

Heit JA. Clin Geriatr Med. 2001;17:71-92.

Heit JA, et al. Mayo Clin Proc. 2001;76:1102-1110.

51

Page 20: Bratzler - Health Services Advisory Group

Surgical Care Improvement ProjectPerformance measures - Process

• Prevention of venous thromboembolism• Surgery patients with recommended

VTE prophylaxis ordered

• Surgery Patients Who Received Appropriate Venous Thromboembolism Prophylaxis Within 24 Hours Prior to Surgery to 24 Hours After Surgery

55

Based on the 2004 ACCP Consensus Recommendations

Page 21: Bratzler - Health Services Advisory Group

www.medqic.org/scip